Reduction of the systemic inflammatory induced by acute cerebral infarction through ultra‑early thrombolytic therapy

Ye,Lichao; Cai,Ruowei; Yang,Meili; Qian,Jiaqiang; Hong,Zhilin

doi:10.3892/etm.2015.2672

Reduction of the systemic inflammatory induced by acute cerebral infarction through ultra‑early thrombolytic therapy

Authors:
- Lichao Ye
- Ruowei Cai
- Meili Yang
- Jiaqiang Qian
- Zhilin Hong
View Affiliations

Affiliations: Department of Neurology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, P.R. China
Published online on: August 6, 2015 https://doi.org/10.3892/etm.2015.2672
Pages: 1493-1498

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Acute ischemic stroke induces systemic inflammation, exhibited as changes in body temperature, white blood cell counts and C‑reactive protein (CRP) levels. The aim of the present study was to observe the effects of intravenous thrombolytic therapy on inflammatory indices in order to investigate the hypothesis that post‑stroke systemic inflammatory response occurs in response to the necrosis of brain tissues. In this study, 62 patients with acute cerebral infarction and indications for intravenous thrombolysis were divided into three groups on the basis of their treatment and response: Successful thrombolysis (n=36), failed thrombolysis (n=12) and control (n=14) groups. The body temperature, white blood cell counts and high-sensitivity (hs)-CRP levels were recorded pre‑treatment and on post‑stroke days 1, 3, 5 and 7. Spearman's correlation analysis showed that the pre‑treatment National Institutes of Health Stroke Scale (NIHSS) score positively correlated with body temperature, white blood cell count and hs‑CRP levels. On day 3 of effective intravenous thrombolysis, the body temperature and white blood cell were decreased and on days 3 and 5, the serum levels of hs‑CRP were reduced compared with those in the failed thrombolysis and control groups. The results indicate that the systemic inflammatory response following acute cerebral infarction was mainly caused by ischemic injury of local brain tissue; the more serious the stroke, the stronger the inflammatory response. Ultra‑early thrombolytic therapy may inhibit the necrosis of brain tissue and thereby reduce the inflammatory response.

View Figures

View References

1	Zierath D, Thullbery M, Hadwin J, Gee JM, Savos A, Kalil A and Becker KJ: CNS immune responses following experimental stroke. Neurocrit Care. 12:274–284. 2010. View Article : Google Scholar : PubMed/NCBI
2	Nakase T, Yamazaki T, Ogura N, Suzuki A and Nagata K: The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. J Neurol Sci. 271:104–109. 2008. View Article : Google Scholar : PubMed/NCBI
3	Wang Q, Tang XN and Yenari MA: The inflammatory response in stroke. J Neuroimmunol. 184:53–68. 2007. View Article : Google Scholar : PubMed/NCBI
4	ShenharTsarfaty S, Assayag EB, Bova I, Shopin L, Berliner S, Shapira I and Bornstein NM: Early signaling of inflammation in acute ischemic stroke: Clinical and rheological implications. Thromb Res. 122:167–173. 2008. View Article : Google Scholar : PubMed/NCBI
5	McColl BW, Allan SM and Rothwell NJ: Systemic inﬂammation and stroke: Aetiology, pathology and targets for therapy. Biochem Soc Trans. 35:1163–1165. 2007. View Article : Google Scholar : PubMed/NCBI
6	Sotgiu S, Zanda B, Marchetti B, Fois ML, Arru G, Pes GM, Salaris FS, Arru A, Pirisi A and Rosati G: Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol. 13:505–513. 2006. View Article : Google Scholar : PubMed/NCBI
7	Harms H, Prass K, Meisel C, Klehmet J, Rogge W, Drenckhahn C, Göhler J, Bereswill S, Göbel U, Wernecke KD, et al: Preventive antibacterial therapy in acute ischemic stroke: A randomized controlled trial. PLoS One. 3:e21582008. View Article : Google Scholar : PubMed/NCBI
8	Schwarz S, Al-Shajlawi F, Sick C, Meairs S and Hennerici MG: Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke: The Mannheim Infection in Stroke Study (MISS). Stroke. 39:1220–1227. 2008. View Article : Google Scholar : PubMed/NCBI
9	Ad Hoc Committee representing the National Stroke Foundation and the Stroke Society of Australasia: The implementation of intravenous tissue plasminogen activator in acute ischaemic stroke - a scientific position statement from the National Stroke Foundation and the Stroke Society of Australasia. Intern Med J. 39:317–324. 2009. View Article : Google Scholar : PubMed/NCBI
10	AdamsHP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, et al: Guidelines for the early management of adults with ischaemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 38:1655–1711. 2007. View Article : Google Scholar : PubMed/NCBI
11	AdamsHP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL and Marsh EE III: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 24:35–41. 1993. View Article : Google Scholar : PubMed/NCBI
12	Naess H, Idicula T, Lagallo N, Brogger J, WajeAndreassen U and Thomassen L: Inverse relationship of baseline body temperature and outcome between ischemic stroke patients treated and not treated with thrombolysis: The Bergen stroke study. Acta Neurol Scand. 122:414–417. 2010. View Article : Google Scholar : PubMed/NCBI
13	Saini M, Saqqur M, Kamruzzaman A, Lees KR and Shuaib A: VISTA Investigators: Effect of hyperthermia on prognosis after acute ischemic stroke. Stroke. 40:3051–3059. 2009. View Article : Google Scholar : PubMed/NCBI
14	Greer DM, Funk SE, Reaven NL, Ouzounelli M and Uman GC: Impact of fever on outcome in patients with stroke and neurologic injury: A comprehensive meta-analysis. Stroke. 39:3029–3035. 2008. View Article : Google Scholar : PubMed/NCBI
15	Leira R, Sobrino T, Blanco M, Campos F, Rodríguez-Yáñez M, Castellanos M, Moldes O, Millán M, Dávalos A and Castillo J: A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA). Clin Sci (Lond). 122:113–119. 2012. View Article : Google Scholar : PubMed/NCBI
16	Wang Y, Lim LL, Levi C, Heller RF and Fisher J: Influence of admission body temperature on stroke mortality. Stroke. 31:404–409. 2000. View Article : Google Scholar : PubMed/NCBI
17	Kammersgaard LP, Jørgensen HS, Rungby JA, Reith J, Nakayama H, Weber UJ, Houth J and Olsen TS: Admission body temperature predicts long-term mortality after acute stroke: The Copenhagen Stroke Study. Stroke. 33:1759–1762. 2002. View Article : Google Scholar : PubMed/NCBI
18	Karaszewski B, Thomas RG, Dennis MS and Wardlaw JM: Temporal profile of body temperature in acute ischemic stroke: Relation to stroke severity and outcome. BMC Neurol. 12:1232012. View Article : Google Scholar : PubMed/NCBI
19	den Hertog HM, van der Worp HB, van Gemert HM, Algra A, Kappelle LJ, van Gijn J, Koudstaal PJ and Dippel DW: An early rise in body temperature is related to unfavorable outcome after stroke: Data from the PAIS study. J Neurol. 258:302–307. 2011. View Article : Google Scholar : PubMed/NCBI
20	Leira R, Rodríguez-Yáñez M, Castellanos M, Blanco M, Nombela F, Sobrino T, Lizasoain I, Dávalos A and Castillo J: Hyperthermia is a surrogate marker of inflammation-mediated cause of brain damage in acute ischaemic stroke. J Intern Med. 260:343–349. 2006. View Article : Google Scholar : PubMed/NCBI
21	Hurn PD, Subramanian S, Parker SM, Afentoulis ME, Kaler LJ, Vandenbark AA and Offner H: T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab. 27:1798–1805. 2007. View Article : Google Scholar : PubMed/NCBI
22	Smith CJ, Emsley HC, Gavin CM, Georgiou RF, Vail A, Barberan EM, del Zoppo GJ, Hallenbeck JM, Rothwell NJ, Hopkins SJ and Tyrrell PJ: Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 4:22004. View Article : Google Scholar : PubMed/NCBI
23	Christensen H and Boysen G: C-reactive protein and white blood cell count increases in the first 24 h after acute stroke. Cerebrovasc Dis. 18:214–219. 2004. View Article : Google Scholar : PubMed/NCBI
24	Akopov SE, Simonian NA and Grigorian GS: Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. Stroke. 27:1739–1743. 1996. View Article : Google Scholar : PubMed/NCBI
25	EliasSmale SE, Kardys I, Oudkerk M, Hofman A and Witteman JC: C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; results from the Rotterdam study. Atherosclerosis. 195:e195–e202. 2007. View Article : Google Scholar : PubMed/NCBI
26	Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, et al: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 359:2195–2207. 2008. View Article : Google Scholar : PubMed/NCBI
27	Idicula TT, Brogger J, Naess H, WajeAndreassen U and Thomassen L: Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: The ‘Bergen stroke study’. BMC Neurol. 9:182009. View Article : Google Scholar : PubMed/NCBI
28	den Hertog HM, van Rossum JA, van der Worp HB, van Gemert HM, de Jonge R, Koudstaal PJ and Dippel DW: PAIS investigators: C-reactive protein in the very early phase of acute ischemic stroke: Association with poor outcome and death. J Neurol. 256:2003–2008. 2009. View Article : Google Scholar : PubMed/NCBI
29	Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, et al: Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Engl J Med. 359:1317–1329. 2008. View Article : Google Scholar : PubMed/NCBI
30	Audebert HJ, Rott MM, Eck T and Haberl RL: Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke. 35:2128–2133. 2004. View Article : Google Scholar : PubMed/NCBI
31	Hemmen TM, Raman R, Guluma KZ, Meyer BC, Gomes JA, CruzFlores S, Wijman CA, Rapp KS, Grotta JC and Lyden PD: ICTuS-L Investigators: Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): Final results. Stroke. 41:2265–2270. 2010. View Article : Google Scholar : PubMed/NCBI
32	Idicula TT, WajeAndreassen U, Brogger J, Naess H, Lundstadsveen MT and Thomassen L: The effect of physiologic derangement in patients with stroke treated with thrombolysis. J Stroke Cerebrovasc Dis. 17:141–146. 2008. View Article : Google Scholar : PubMed/NCBI
33	Millan M, Grau L, Castellanos M, Rodríguez-Yáñez M, Arenillas JF, Nombela F, Pérez de la Ossa N, López-Manzanares L, Serena J, Castillo J and Dávalos A: Body temperature and response to thrombolytic therapy in acute ischaemic stroke. Eur J Neurol. 15:1384–1389. 2008. View Article : Google Scholar : PubMed/NCBI